A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DNL201 in Healthy Volunteers
Clinical trial NCT04551534 · COMPLETED
Trial details
- NCT number
- NCT04551534
- Sponsor
- Denali Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-01
- Primary completion
- 2018-08-08
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.